What is Origin Therapeutics Holdings Inc. (ORIG.CN)?

Origin Therapeutics Holdings Inc. (ORIG.CN) is a stock in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. View full analysis on Stocks360.

Origin Therapeutics Holdings Inc. (ORIG.CN)

Stock analysis · CNQ · Healthcare · Drug Manufacturers - Specialty & Generic

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

0.00

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

Origin Therapeutics Holdings Inc. (ORIG.CN) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Origin Therapeutics Holdings Inc.

Origin Therapeutics Holdings Inc. functions as an investment firm, predominantly focusing its efforts on the burgeoning psychedelic industry within Canada. Its strategic intent is to finance various stages of development, including scientific research, product conceptualization, manufacturing, quality control, market penetration, and sales of psychedelic substances, alongside any related endeavors. Incorporated in 2020, the company, originally known as 1278700 B.C. Ltd., maintains its main office in Vancouver, Canada.